Inhibitors of matrix metalloproteinase -> Monitor Keywords
Fresh Patents
Monitor Patents Patent Organizer File a Provisional Patent Browse Inventors Browse Industry Browse Agents Browse Locations
site info Site News  |  monitor Monitor Keywords  |  monitor archive Monitor Archive  |  organizer Organizer  |  account info Account Info  |  
09/18/08 - USPTO Class 514 |  53 views | #20080227858 | Prev - Next | About this Page  514 rss/xml feed  monitor keywords

Inhibitors of matrix metalloproteinase

USPTO Application #: 20080227858
Title: Inhibitors of matrix metalloproteinase
Abstract: R10 and R11 each independently represents H or C1-6 alkyl; and and physiologically functional derivatives thereof, with the exception of N-(ethoxycarbonyl)-N-[4-(1H-tetrazol-1-yl)phenyl]glycine, processes for their preparation, pharmaceutical formulations containing them and their use as inhibitors of matrix metalloproteinase enzymes (MMPs) are described. R8 and R9 each independently represents H or C1-6 alkyl; R6 and R7 each independently represents H, C1-6 alkyl, or C1-6 alkyl substituted with one or more heteroaryl groups, or R6 and R7 together with the nitrogen atom to which they are attached form a 5- or 6-membered ring which may optionally include 1 or more further heteroatoms selected from O, S and N; R4 and R5 each independently represents H, C1-6 alkyl or C1-4 alkylaryl; R3 represents OR6NR6R7 or NR6OH; R2 represents SO2R10 or SO2NR10R11; X represents COR3 or N(OR8)COR9; Q represents an optionally substituted 5- or 6-membered aryl or heteroaryl ring; Z represents a bond, CH2, O, S, SO, SO2, NR4, OCR4R5, CR4R5O, or Z, R1 and Q together form an optionally substituted fused tricyclic group; R1 represents optionally substituted C4-12 alkyl, optionally substituted C2-6alkylaryl, or optionally substituted 5- or 6-membered aryl or heteroaryl; wherein Compounds of formula (I): (end of abstract)



USPTO Applicaton #: 20080227858 - Class: 514521 (USPTO)

Inhibitors of matrix metalloproteinase description/claims


The Patent Description & Claims data below is from USPTO Patent Application 20080227858, Inhibitors of matrix metalloproteinase.

Brief Patent Description - Full Patent Description - Patent Application Claims
  monitor keywords CROSS REFERENCE TO PRIOR APPLICATIONS

This application is a continuation of U.S. application Ser. No. 10/561,055 filed 16 Dec. 2005 (allowed), which is a 371 application of PCT/EP2004/006553 filed 16 Jun. 2004 which claims priority to GB application 0314488.8 filed 20 Jun. 2003.

FIELD OF THE INVENTION

This invention relates to novel chemical compounds, processes for their preparation, pharmaceutical formulations containing them and their use in therapy.

SUMMARY OF THE INVENTION

The compounds of the invention are inhibitors of matrix metalloproteinase enzymes (MMPs).

BACKGROUND OF THE INVENTION

Matrix metalloproteinase enzymes play a major role in extracellular matrix component degradation and remodelling. Examples of MMPs include collagenase 1, 2 and 3, gelatinase A and B, stromelysin 1, 2 and 3, matrilysin, macrophage metalloelastase, enamelysin and membrane type 1, 2, 3 and 4 MMP. The enzymes are secreted by connective tissue cells and inflammatory cells. Enzyme activation can not only initiate tissue damage but induce increased inflammatory cell infiltration into the tissue, leading to more enzyme production and subsequent tissue damage. For example, elastin fragments produced by MMP degradation are believed to stimulate inflammation by attracting macrophages to the site of MMP activity. Inhibition of MMPs provides a means for treating disease states wherein inappropriate metalloprotease activity results in degradation of connective tissue and inflammation.

DETAILED DESCRIPTION OF THE INVENTION

In one aspect, the present invention provides compounds of formula (I):

wherein: R1 represents optionally substituted C4-12 alkyl, optionally substituted C2-6alkylaryl, or optionally substituted 5- or 6-membered aryl or heteroaryl; Z represents a bond, CH2, O, S, SO, SO2, NR4, OCR4R5, CR4R5O, or Z, R1 and Q together form an optionally substituted fused tricyclic group;

Continue reading about Inhibitors of matrix metalloproteinase...
Full patent description for Inhibitors of matrix metalloproteinase

Brief Patent Description - Full Patent Description - Patent Application Claims

Click on the above for other options relating to this Inhibitors of matrix metalloproteinase patent application.
###
monitor keywords

How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Inhibitors of matrix metalloproteinase or other areas of interest.
###


Previous Patent Application:
N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
Next Patent Application:
Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Industry Class:
Drug, bio-affecting and body treating compositions

###

FreshPatents.com Support
Thank you for viewing the Inhibitors of matrix metalloproteinase patent info.
IP-related news and info


Results in 0.06989 seconds


Other interesting Feshpatents.com categories:
Computers:  Graphics I/O Processors Dyn. Storage Static Storage Printers 174
filepatents (1K)

* Protect your Inventions
* US Patent Office filing
patentexpress PATENT INFO